EVOLUTION OF HIGH-DOSE CISPLATIN

被引：0
|
作者：
HOLLERAN, WM
DEGREGORIO, MW
机构：
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,MED ONCOL SECT,POB 3333,333 CEDAR ST,NEW HAVEN,CT 06510
[2] PACIFIC PRESBYTERIAN MED CTR,CHILDRENS CANC RES INST,CANC PHARMACOL & PHARMACOKINET LAB,SAN FRANCISCO,CA 94115
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 142
页数：8
相关论文
共 50 条
  • [31] Nomogram for cumulative cisplatin dose for LAHNC receiving tri-weekly high-dose cisplatin CCRT
    Wang, T.
    Lien, M.
    Hua, C.
    Ching-Yun, H.
    Ming-Hsui, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 21 - 21
  • [32] A COMPARISON OF 2 DOSE LEVELS OF GRANISETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
    SOUKOP, M
    EUROPEAN JOURNAL OF CANCER, 1990, 26 : S15 - S19
  • [33] RENAL TUBULAR FUNCTION IN PATIENTS TREATED WITH HIGH-DOSE CISPLATIN
    DAUGAARD, G
    ABILDGAARD, U
    HOLSTEINRATHLOU, NH
    BRUUNSHUUS, I
    BUCHER, D
    LEYSSAC, PP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) : 164 - 172
  • [34] HIGH-DOSE CISPLATIN WITH DACARBAZINE AND TAMOXIFEN IN THE TREATMENT OF METASTATIC MELANOMA
    BUZAID, AC
    MURREN, JR
    DURIVAGE, HJ
    CANCER, 1991, 68 (06) : 1238 - 1241
  • [35] HIGH-DOSE CISPLATIN PLUS DACARBAZINE IN THE TREATMENT OF METASTATIC MELANOMA
    MURREN, JR
    DEROSA, W
    DURIVAGE, HJ
    DAVIS, C
    MAKUCH, R
    PORTLOCK, CS
    CANCER, 1991, 67 (06) : 1514 - 1517
  • [36] THE INTRAPATIENT EFFECT OF CISPLATIN THERAPY ON THE PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE
    CROM, WR
    TERESI, ME
    MEYER, WH
    GREEN, AA
    EVANS, WE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 467 - 467
  • [37] HIGH-DOSE DEXAMETHASONE FOR PREVENTION OF CISPLATIN-INDUCED VOMITING
    AAPRO, MS
    ALBERTS, DS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 7 (01) : 11 - 14
  • [38] HIGH-DOSE CISPLATIN IN ADVANCED HEAD AND NECK-CANCER
    FORASTIERE, AA
    TAKASUGI, BJ
    BAKER, SR
    WOLF, GT
    KUDLAHATCH, V
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (02) : 155 - 158
  • [39] NEPHROTOXICITY OF HIGH-DOSE INTRACAVITARY CISPLATIN WITH INTRAVENOUS THIOSULFATE PROTECTION
    MARKMAN, M
    CLEARY, S
    HOWELL, SB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (09): : 1015 - 1018
  • [40] Ondansetron significantly reduces the AUC of high-dose cyclophosphamide and cisplatin
    Reactions Weekly, 1999, 765 (1) : 4 - 4
12345